Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Dizziness | common | x | x | |
Headache | common | x | x | |
Hypotension | common | x | x | |
Nausea | common | x | x | |
Vomiting | common | x | x | |
Abdominal pain | rare | x | ||
Adrenal insufficiency | rare | x | ||
Dermatitis atopic | rare | x | ||
Hirsutism | rare | x | ||
Alopecia | x | |||
Endocrine disorder | x | |||
Gastrointestinal disorder | x | |||
Hypertension | x | |||
Nervous system disorder | x | |||
Pain | x | |||
Pancytopenia | x | |||
Angiopathy | x | |||
Bone marrow depression | x | |||
Unspecified disorder of skin and subcutaneous tissue | x | |||
Abdominal discomfort | x | |||
White blood cell count decreased | x | |||
Allergic rash | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |